Rivaroxaban vs Apixaban and Ischemic or Hemorrhagic Events in Patients With Atrial Fibrillation-Reply
- PMID: 35380586
- PMCID: PMC9885888
- DOI: 10.1001/jama.2022.1428
Rivaroxaban vs Apixaban and Ischemic or Hemorrhagic Events in Patients With Atrial Fibrillation-Reply
Comment on
-
Rivaroxaban vs Apixaban and Ischemic or Hemorrhagic Events in Patients With Atrial Fibrillation.JAMA. 2022 Apr 5;327(13):1290. doi: 10.1001/jama.2022.1425. JAMA. 2022. PMID: 35380590 No abstract available.
References
-
- Ferro EG, Kazi DS, Zimetbaum PJ. Informing the Choice of Direct Oral Anticoagulant Therapy in Patients With Atrial Fibrillation. JAMA. 2021; 326(23):2372–2374. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
